insights_auto
Why is GUTS down 9.66%?
Dive Deeperchevron_right
GUTS:NASDAQ
Fractyl Health Inc
$0.41
arrow_downward
-9.66%(-0.044) 1D
$0.40
arrow_downward
-1.62% (-0.0066)bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUTS...
Open
$0.45
High
$0.45
Low
$0.40
Mkt. cap
64.74M
Avg. vol.
1.89M
Volume
3.06M
52-wk high
$2.44
52-wk low
$0.38
EPS
-$1.12
Shares outstanding
159.18M
No. of employees
100
Open
$0.45
High
$0.45
Low
$0.40
Mkt. cap
64.74M
Avg. vol.
1.89M
Volume
3.06M
52-wk high
$2.44
52-wk low
$0.38
EPS
-$1.12
Shares outstanding
159.18M
No. of employees
100
News stories
From web sources and news partners
MarketBeat
·
27 minutes ago
JFrog Ltd. (NASDAQ:FROG) Stock Has Consensus Target Price of $109.48 According to Analysts
eGamers.io
·
27 minutes ago
Evernorth’s Nasdaq Debut Puts a $2 XRP Target in Play — but Only if Demand Holds
Simply Wall Street
·
1 hour ago
What Comes Next For Arrowhead Pharmaceuticals After The 78% Run
Business Insider
·
21 hours ago
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Profile
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1. Wikipedia
About Fractyl Health Inc
CEO-
Employees100
Founded2010
HeadquartersBurlington, Massachusetts, United States
SectorMedical device
Websitefractyl.com